Rising Prevalence Driving India Thalassemia Market Growth
The rising prevalence of thalassemia in India is a key driver for the India Thalassemia Market. Factors such as genetic inheritance patterns and lack of early diagnosis contribute to increased patient numbers.The market was valued at USD 310 million in 2023 and is projected to reach USD 485 million by 2032, with a CAGR of 5.6%. Hospitals and specialized clinics play a pivotal role in delivering treatments, including transfusions and chelation therapy.Government initiatives, public awareness campaigns, and improved screening methods are enhancing early detection and management of thalassemia.The India Thalassemia Market forecast suggests sustained growth over the coming years, particularly with the expansion of advanced treatment facilities and increased accessibility in regional healthcare centers.